Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19
The study is conducted in New York, New York at The Cohen Center for Recovery from
Complex Chronic Illness at Mount Sinai.
This is an IND-exempt, off-label, multi-ascending, randomized, placebo-controlled
clinical trial of sirolimus (also known as rapamycin) in adu...
Age: 18 years - 66+
Gender: All
Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
This will be a pilot multi-arm clinical trial investigating the feasibility of 6 weeks of Lumbrokinase (LK) as an intervention in three clinical cohorts:
Long Covid (LC)
Post-treatment Lyme disease syndrome (PTLDS)
Myalgic encephalomyelitis/chronic fatigue syndrome (ME...
Age: 18 years - 66+
Gender: All
Humanity Neurotech Device Clinical Trial in Adults with Long COVID Cognitive Dysfunction
The purpose of this study is to assess the feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to PASC, and to collect data on safety and efficacy to inform the design of larger clinical studies. A prospective randomized controlled stu...
Age: 18 - 65 years
Gender: All
Investigating the feasibility of repurposing HIV antivirals in Adults with Long Covid
The trial will test if two repurposed HIV antivirals can reduce symptom burden in adult participants with Long Covid compared to placebo. Viral infection and viral reactivation have been documented in Long Covid.Participants will be randomly allocated to receive antivir...
Age: 18 years - 66+
Gender: All
RECOVER-SLEEP: Platform Protocol
The platform protocol is designed to be flexible so that it is suitable for a range of
study settings and intervention types. Therefore, the platform protocol provides a
general protocol structure that can be shared by multiple interventions and allows
comparative an...
Age: 18 years - 66+
Gender: All
RECOVER-SLEEP: Platform Protocol
The platform protocol is designed to be flexible so that it is suitable for a range of
study settings and intervention types. Therefore, the platform protocol provides a
general protocol structure that can be shared by multiple interventions and allows
comparative an...
Age: 18 years - 66+
Gender: All
Study of Obeldesivir in Nonhospitalized Participants With COVID-19
The goal of this clinical study is to test if obeldesivir (formerly GS-5245) is safe and
effective for the treatment of coronavirus disease 2019 (COVID-19) in participants who have a
standard risk of developing severe illness. This study will also measure how much o...
Age: 12 - 64 years
Gender: All
Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)
Treatments are needed to improve outcomes among patients hospitalized for COVID-19,
including direct-acting antiviral (DAA) agents to mitigate the pathology driven by
ongoing viral replication. This trial will evaluate S-217622 (ensitrelvir), an
anti-SARS-CoV2 3C-lik...
Age: 18 years - 66+
Gender: All
A Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults
The primary objective of the study is to evaluate the effect of casirivimab+imdevimab, compared with placebo, in preventing symptomatic SARS-CoV-2 infection in immunocompromised participants. The secondary objectives of the study are: - To evaluate the safety and tolera...
Age: 12 years - 66+
Gender: All
To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.
Substudy A: The study will evaluate the safety, tolerability, and efficacy of a booster dose
of BNT162b2 when administered to participants having previously received 2 doses of BNT162b2
at least 6 months prior to randomization.
The study is designed to describe ...
Age: 16 years - 66+
Gender: All
To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.
Substudy A: The study will evaluate the safety, tolerability, and efficacy of a booster dose
of BNT162b2 when administered to participants having previously received 2 doses of BNT162b2
at least 6 months prior to randomization.
The study is designed to describe ...
Age: 16 years - 66+
Gender: All
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
The primary objective of the Outpatient Treatment with Anti-Coronavirus Immunoglobulin
(OTAC) (INSIGHT 012) trial is to compare the safety and efficacy of a single infusion of
anti-COVID-19 hyperimmune intravenous immunoglobulin (hIVIG) versus placebo among adults
wi...
Age: 18 years - 66+
Gender: All
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
The primary objective of the Outpatient Treatment with Anti-Coronavirus Immunoglobulin
(OTAC) (INSIGHT 012) trial is to compare the safety and efficacy of a single infusion of
anti-COVID-19 hyperimmune intravenous immunoglobulin (hIVIG) versus placebo among adults
wi...
Age: 18 years - 66+
Gender: All
Impact of COVID-19 on GU Disease
The purpose of this research study is to identify patients with GU disease with active or
past COVID-19 infection.
Participants will be asked to:
- Complete an Online COVID-19 Questionnaire.
- Disclose if the patient has or had Genitourinary cancer or beni...
Age: 40 years - 66+
Gender: All
Comparative Effectiveness of Telemedicine in Primary Care
Leveraging a natural experiment approach, the investigators will examine rapidly changing
telemedicine and in-person models of care during and after the COVID-19 crisis to determine
whether certain patients could safely choose to continue telemedicine or
telemedic...
Age: 19 years - 66+
Gender: All
Early CPAP in COVID-19 Confirmed or Suspected Patients
There is surge in COVID infected patients in New York City with a shortage of hospital beds,
ICU beds and ventilators. Strategies to reduce the need for all of the above are immediately
needed. Further, few interventions are targeted in COVID infected patients early...
Age: 18 years - 66+
Gender: All
Early CPAP in COVID-19 Confirmed or Suspected Patients
There is surge in COVID infected patients in New York City with a shortage of hospital beds,
ICU beds and ventilators. Strategies to reduce the need for all of the above are immediately
needed. Further, few interventions are targeted in COVID infected patients early...
Age: 18 years - 66+
Gender: All
Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC )
Endothelial injury as a consequence of SARS-CoV-2 infection leads to a dysregulated host
inflammatory response and activation of coagulation pathways. Macro- and micro-vascular
thrombosis may contribute to morbidity, organ failure, and death. Therapeutic anticoagulati...
Age: 18 years - 66+
Gender: All
Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC )
Endothelial injury as a consequence of SARS-CoV-2 infection leads to a dysregulated host inflammatory response and activation of coagulation pathways. Macro- and micro-vascular thrombosis may contribute to morbidity, organ failure, and death. Therapeutic anticoagulation...
Age: 18 years - 66+
Gender: All